In our top 10 of 2021, we take a look back at the factors that are increasing demand for cold chain storage, transport, and distribution solutions—including the growth of cell and gene therapies.
By 2024 experts predict that five out of the top ten best-selling drugs will require refrigerated storage and handling. Between 2018 and 2024 there is a projected 50% growth in global biopharma sales for cold chain products, growing at approximately twice the rate of non-cold chain products.
At HDA’s Distribution Management Conference, Ann Pham, director of business development at third party logistics provider ICS, discussed cold chain considerations from a 3PL’s point of view. She said that COVID-19 caused significant disruption to pharmaceutical supply channels, but the pandemic alerted the entire industry to become better prepared in the event of a future incident.
Continue to the full article here: Cold Chain Logistics: Poised for Growth with Lessons Learned from the Pandemic
